再構築皮膚モデルの2030年までの世界市場予測：タイプ別、用途別、エンドユーザー別、地域別分析

Stratistics MRCによると、世界の再構築皮膚モデル市場は2023年に3,740万米ドルを占め、予測期間中にCAGR 15.0％で成長し、2030年には9,970万米ドルに達する見込みです。

再構築皮膚モデルは、人間の皮膚の特性や機能を模倣した実験室製造の構造物です。これらのモデルは通常、足場やマトリックス上で増殖した細胞の層で構成され、表皮、真皮、場合によっては皮下層を再現します。製薬、化粧品、医学の研究において、皮膚生理学、毒性試験、スキンケア製品や治療法の有効性を研究するために使用されます。

米国皮膚科学会が発表した2022年の統計によると、米国では毎日約9,500人が皮膚がんと診断されていると報告されています。

動物実験に代わるものへの需要の高まり

再構築皮膚モデルは、動物実験の必要性に取って代わる、人道的かつ倫理的な試験アプローチを提供します。さらに、ヒトの皮膚生理や様々な物質に対する反応を忠実に模倣しているため、より正確で信頼性の高い結果を得ることができます。動物実験に対する規制が強化され、動物福祉に対する意識が高まる中、再構築皮膚モデルの採用は大幅に増加すると予想されます。

開発と検証にかかる高いコスト

正確で信頼性の高い皮膚モデルの作成には、高度な実験施設、特殊な機器、熟練した人材が必要であり、多額の投資が必要となります。さらに、モデルがヒトの皮膚生理を正確に再現していることを確認するための厳密な検証試験を実施することも、コストに拍車をかける。これらの費用は、小規模の研究機関や企業にとっては法外なものであり、再構築皮膚モデルの開発・採用が制限される可能性があります。さらに、長くて複雑な検証プロセスは、新しいモデルの商業化を遅らせ、その普及と市場成長の妨げとなる可能性があります。

組織工学の技術的進歩

細胞培養技術、生体材料、3Dプリンティング技術の革新により、より洗練された生理学的に適切な皮膚モデルの開発が可能になった。これらの進歩により、研究者は精度、機能性、再現性を向上させたモデルを作成し、人間の皮膚生理や病理をよりよく模倣することができます。さらに、自動化とハイスループットスクリーニング技術の進歩により、再構築皮膚モデルの迅速かつコスト効率の高い作製と検証が容易になり、市場の成長を促進しています。

標準化の欠如

モデルの開発、検証、使用に関する普遍的に認められたプロトコルやガイドラインがないため、モデルの品質、性能、再現性に研究室や研究ごとのばらつきが生じる。この矛盾は、研究結果の信頼性と比較可能性を損ない、規制試験や産業応用における皮膚再構築モデルの採用を妨げます。さらに、標準化された方法論がなければ、データの不一致や誤った解釈が生じる危険性があり、利害関係者の間で不確実性や懐疑論が生じることになります。

COVID-19の影響：

COVID-19パンデミックは、研究活動とサプライチェーンを混乱させることにより、再構築皮膚モデル市場に影響を与えました。研究所の閉鎖、渡航制限、社会的距離を置く措置が、モデル開発と検証研究の遅れにつながった。さらに、COVID関連以外の研究に割り当てられた資金や資源の減少が、市場の進展をさらに遅らせています。しかし、パンデミックは代替検査法の重要性も浮き彫りにしており、将来的には再構築皮膚モデルの需要を牽引する可能性があります。

予測期間中、化粧品検査分野が最大となる見込み

化粧品試験分野は、動物実験に対する規制の高まりと、無残で安全な化粧品に対する消費者の需要の高まりにより、予測期間中、皮膚再構築モデル市場をリードすると予測されます。再構築皮膚モデルは、動物実験を必要とせずに化粧品の安全性、有効性、毒性を評価するための信頼できる代替手段を提供します。さらに、モデル技術の進歩と倫理的で持続可能な実践に対する意識の高まりが、化粧品試験における皮膚再構築モデルの採用をさらに後押ししています。

受託研究機関（CRO）セグメントは、予測期間中に最も高いCAGRを示すと予想されます。

受託研究機関（CRO）セグメントは、予測期間中に再構築皮膚モデル市場で最も高い成長率を達成すると予測されています。この成長は、製薬、化粧品、医療機器企業によるCROへの研究および試験活動のアウトソーシングが増加していることに起因しています。これらの組織は、再構築皮膚モデルを用いた安全性試験や有効性試験を含む前臨床試験の実施を専門としており、製品開発や規制遵守のための費用対効果に優れた効率的なソリューションを提供しています。

最もシェアの高い地域：

予測期間中、北米地域は、ヘルスケアおよび製薬産業が堅調で、研究開発活動が盛んであることから、再構築皮膚モデル市場をリードする見通しです。同地域は規制基準が厳しく、再建皮膚模型のような信頼性が高く正確な検査方法に対する需要を牽引しています。さらに、化粧品や医薬品の倫理的で効果的な試験方法の重要性に対する認識が高まっていることも、北米市場の成長に寄与しています。

CAGRが最も高い地域：

予測期間中、欧州は再建用皮膚モデル市場で大きな成長を遂げると予想されます。欧州は、確立された製薬・化粧品産業を誇り、安全性と有効性試験を優先する厳格な規制基準と相まっています。さらに、研究開発への投資の増加や、倫理的で正確な試験のための再構築皮膚モデルの利点に関する意識の高まりが、この地域の市場成長を促進しています。これらの要因により、欧州は再構築皮膚モデルの主要成長市場として位置づけられています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の再構築皮膚モデル市場：タイプ別

• 表皮皮膚モデル
• 真皮モデル
• 3D再構築皮膚モデル

第6章 世界の再構築皮膚モデル市場：用途別

• 化粧品試験
  • 皮膚刺激性試験
  • 皮膚感作性試験
• 化学物質および毒性試験
• その他の用途

第7章 世界の再構築皮膚モデル市場：エンドユーザー別

• 受託調査機関（CRO）
• 化粧品会社
• 製薬会社およびバイオテクノロジー会社
• 研究機関と学術界
• その他のエンドユーザー

第8章 世界の再構築皮膚モデル市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• AIVITA Biomedical
• Biopredic International
• CellSystems
• CellTechMed GmbH
• Genoskin
• LabSkin Creations
• L'Oreal S.A.
• MatTek Corporation
• OrSkin
• QGel SA
• SkinEthic Laboratories
• StratiCELL
• Tissue Regeneration Sciences, Inc.
• VITROCELL Systems GmbH

List of Tables

• Table 1 Global Reconstructed Skin Models Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
• Table 4 Global Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
• Table 5 Global Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
• Table 6 Global Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
• Table 7 Global Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
• Table 8 Global Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
• Table 9 Global Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
• Table 10 Global Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
• Table 11 Global Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 12 Global Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
• Table 13 Global Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
• Table 14 Global Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
• Table 15 Global Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 16 Global Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
• Table 17 Global Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 18 North America Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
• Table 19 North America Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
• Table 20 North America Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
• Table 21 North America Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
• Table 22 North America Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
• Table 23 North America Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
• Table 24 North America Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
• Table 25 North America Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
• Table 26 North America Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
• Table 27 North America Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
• Table 28 North America Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 29 North America Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
• Table 30 North America Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
• Table 31 North America Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
• Table 32 North America Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 33 North America Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
• Table 34 North America Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 35 Europe Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
• Table 36 Europe Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
• Table 37 Europe Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
• Table 38 Europe Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
• Table 39 Europe Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
• Table 40 Europe Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
• Table 41 Europe Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
• Table 42 Europe Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
• Table 43 Europe Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
• Table 44 Europe Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
• Table 45 Europe Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 46 Europe Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
• Table 47 Europe Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
• Table 48 Europe Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
• Table 49 Europe Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 50 Europe Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
• Table 51 Europe Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 52 Asia Pacific Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
• Table 53 Asia Pacific Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
• Table 54 Asia Pacific Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
• Table 55 Asia Pacific Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
• Table 56 Asia Pacific Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
• Table 57 Asia Pacific Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
• Table 58 Asia Pacific Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
• Table 59 Asia Pacific Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
• Table 60 Asia Pacific Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
• Table 61 Asia Pacific Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
• Table 62 Asia Pacific Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 63 Asia Pacific Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
• Table 64 Asia Pacific Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
• Table 65 Asia Pacific Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
• Table 66 Asia Pacific Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 67 Asia Pacific Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
• Table 68 Asia Pacific Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 69 South America Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
• Table 70 South America Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
• Table 71 South America Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
• Table 72 South America Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
• Table 73 South America Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
• Table 74 South America Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
• Table 75 South America Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
• Table 76 South America Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
• Table 77 South America Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
• Table 78 South America Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
• Table 79 South America Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 80 South America Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
• Table 81 South America Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
• Table 82 South America Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
• Table 83 South America Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 84 South America Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
• Table 85 South America Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 86 Middle East & Africa Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
• Table 87 Middle East & Africa Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
• Table 88 Middle East & Africa Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
• Table 89 Middle East & Africa Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
• Table 90 Middle East & Africa Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
• Table 91 Middle East & Africa Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
• Table 92 Middle East & Africa Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
• Table 93 Middle East & Africa Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
• Table 94 Middle East & Africa Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
• Table 95 Middle East & Africa Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
• Table 96 Middle East & Africa Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 97 Middle East & Africa Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
• Table 98 Middle East & Africa Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
• Table 99 Middle East & Africa Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
• Table 100 Middle East & Africa Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 101 Middle East & Africa Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
• Table 102 Middle East & Africa Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Reconstructed Skin Models Market is accounted for $37.4 million in 2023 and is expected to reach $99.7 million by 2030 growing at a CAGR of 15.0% during the forecast period. Reconstructed skin models are laboratory-produced structures that mimic the properties and functions of human skin. These models typically consist of layers of cells grown on scaffolds or matrices, replicating the epidermis, dermis, and sometimes the subcutaneous layer. They are used in pharmaceutical, cosmetic, and medical research to study skin physiology, toxicity testing, and the efficacy of skincare products and treatments.

According to 2022 statistics published by American Academy of Dermatology, it was reported that approximately 9,500 people are diagnosed with skin cancer every day in the U.S.

Market Dynamics:

Driver:

Growing demand for alternatives to animal testing

Reconstructed skin models offer a humane and ethical approach to testing, replacing the need for animal experimentation. Additionally, they provide more accurate and reliable results, as they closely mimic human skin physiology and response to various substances. With increasing regulatory restrictions on animal testing and rising awareness of animal welfare concerns, the adoption of reconstructed skin models is expected to rise significantly.

Restraint:

High cost of development and validation

Creating accurate and reliable skin models requires sophisticated laboratory facilities, specialized equipment, and skilled personnel, which entail substantial investments. Additionally, conducting rigorous validation studies to ensure the models accurately replicate human skin physiology further adds to the cost. These expenses can be prohibitive for smaller research institutions and companies, limiting their ability to develop and adopt reconstructed skin models. Moreover, the lengthy and complex validation process may delay the commercialization of new models, hindering their widespread adoption and market growth.

Opportunity:

Technological advancements in tissue engineering

Innovations in cell culture techniques, biomaterials, and 3D printing technologies enable the development of more sophisticated and physiologically relevant skin models. These advancements allow researchers to create models with improved accuracy, functionality, and reproducibility, better mimicking human skin physiology and pathology. Additionally, advancements in automation and high-throughput screening techniques facilitate the rapid and cost-effective generation and validation of reconstructed skin models, driving market growth.

Threat:

Lack of standardization

The absence of universally accepted protocols and guidelines for model development, validation, and usage results in variability in model quality, performance, and reproducibility across different laboratories and research studies. This inconsistency undermines the reliability and comparability of research findings, hindering the adoption of reconstructed skin models in regulatory testing and industrial applications. Moreover, without standardized methodologies, there is a risk of data discrepancies and misinterpretation, leading to uncertainty and skepticism among stakeholders.

Covid-19 Impact:

The COVID-19 pandemic has impacted the reconstructed skin models market by disrupting research activities and supply chains. Laboratory closures, travel restrictions, and social distancing measures have led to delays in model development and validation studies. Additionally, reduced funding and resources allocated to non-COVID-related research have further slowed progress in the market. However, the pandemic has also highlighted the importance of alternative testing methods, potentially driving future demand for reconstructed skin models.

The cosmetics testing segment is expected to be the largest during the forecast period

The cosmetics testing segment is projected to lead the reconstructed skin models market during the forecast period due to increasing regulatory restrictions on animal testing and rising consumer demand for cruelty-free and safe cosmetic products. Reconstructed skin models offer a reliable alternative for assessing the safety, efficacy, and toxicity of cosmetics without the need for animal testing. Additionally, advancements in model technology and growing awareness of ethical and sustainable practices further drive the adoption of reconstructed skin models in cosmetics testing.

The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period

The contract research organizations (CROs) segment is anticipated to achieve the highest growth rate in the reconstructed skin models market during the forecast period. This growth can be attributed to the increasing outsourcing of research and testing activities by pharmaceutical, cosmetic, and medical device companies to CROs. These organizations specialize in conducting preclinical studies, including safety and efficacy testing using reconstructed skin models, offering cost-effective and efficient solutions for product development and regulatory compliance.

Region with largest share:

During the forecast period, the North American region is poised to lead the reconstructive skin models market owing to its robust healthcare and pharmaceutical industries and high levels of research and development activities. The region has stringent regulatory standards, driving the demand for reliable and accurate testing methods such as reconstructed skin models. Additionally, increasing awareness about the importance of ethical and effective testing methods for cosmetic and pharmaceutical products further contributes to the market's growth in North America.

Region with highest CAGR:

During the forecast period, Europe is expected to experience significant growth in the reconstructive skin models market. Europe boasts a well-established pharmaceutical and cosmetic industry, coupled with stringent regulatory standards that prioritize safety and efficacy testing. Additionally, increasing investments in research and development, along with growing awareness about the benefits of reconstructed skin models for ethical and accurate testing, are driving market growth in the region. These factors position Europe as a key growth market for reconstructive skin models.

Key players in the market

Some of the key players in Reconstructed Skin Models Market include AIVITA Biomedical, Biopredic International, CellSystems, CellTechMed GmbH, Genoskin, LabSkin Creations, L'Oreal S.A. , MatTek Corporation, OrSkin, QGel SA, SkinEthic Laboratories, StratiCELL, Tissue Regeneration Sciences, Inc. and VITROCELL Systems GmbH.

Key Developments:

In June 2023, L'Oreal announced a partnership with the University of California (UC) Berkeley's biotech incubator Bakar Labs. The collaboration opens up avenues for Bakar Labs' incubated startups to benefit from and gain access to L'Oreal's 3D reconstructed skin models, at no cost.

In March 2023, Chanel Research has just made a strategic leap forward to accelerate its knowledge of skin pigment spots, a major aesthetic concern among aging populations, particularly in Asia. In partnership with LabSkin Creations, the luxury giant has successfully used 3D bioprinting techniques to create reconstructed human skin on which a dark spot can appear.

Types Covered:

• Epidermal Skin Models
• Dermal Skin Models
• 3D Reconstructed Skin Models

Applications Covered:

• Cosmetics Testing
• Chemicals and Toxicology Testing
• Other Applications

End Users Covered:

• Contract Research Organizations (CROs)
• Cosmetic Companies
• Pharmaceutical and Biotechnology Companies
• Research Institutes and Academia
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Reconstructed Skin Models Market, By Type

• 5.1 Introduction
• 5.2 Epidermal Skin Models
• 5.3 Dermal Skin Models
• 5.4 3D Reconstructed Skin Models

6 Global Reconstructed Skin Models Market, By Application

• 6.1 Introduction
• 6.2 Cosmetics Testing
  • 6.2.1 Skin Irritation Test
  • 6.2.2 Skin Sensitization Test
• 6.3 Chemicals and Toxicology Testing
• 6.4 Other Applications

7 Global Reconstructed Skin Models Market, By End User

• 7.1 Introduction
• 7.2 Contract Research Organizations (CROs)
• 7.3 Cosmetic Companies
• 7.4 Pharmaceutical and Biotechnology Companies
• 7.5 Research Institutes and Academia
• 7.6 Other End Users

8 Global Reconstructed Skin Models Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 AIVITA Biomedical
• 10.2 Biopredic International
• 10.3 CellSystems
• 10.4 CellTechMed GmbH
• 10.5 Genoskin
• 10.6 LabSkin Creations
• 10.7 L'Oreal S.A.
• 10.8 MatTek Corporation
• 10.9 OrSkin
• 10.10 QGel SA
• 10.11 SkinEthic Laboratories
• 10.12 StratiCELL
• 10.13 Tissue Regeneration Sciences, Inc.
• 10.14 VITROCELL Systems GmbH